30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Joshua Kazam

Track

Insider profile

Currently holds positions in Allogene Therapeutics Inc, Kite Pharma Inc and Capricor Therapeutics Inc

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Co-Founder, Director Allogene Therapeutics Inc June 1, 2018 -
Director Kite Pharma Inc June 1, 2009 -
Director Capricor Therapeutics Inc Aug. 6, 2012 -
Independent Director Nominee Target Hospitality Corp None -
President, Co-Founder, Director Allogene Therapeutics Inc Nov. 1, 2017 - June 1, 2018
President, Chief Executive Officer, Director Capricor Therapeutics Inc June 11, 2009 - Aug. 6, 2012
Joshua Kazam's trades of Allogene Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-01-14 2022-01-12
B Purchase
43,023 -46.7%
223.01
US$3,034,379 		43,023 -46.7% 223.01 US$3,034,379
2021-02-16 2021-02-12
B Purchase
39,299
239.51
US$3,007,179 		39,299 239.51 US$3,007,179
2019-03-05 2019-03-05
B Purchase
57,536 +5.3%
189.16
US$4,634,089 		57,536 +5.3% 189.16 US$4,634,089
2019-03-01 2019-03-01
B Purchase
5,000 +inf%
10.13
US$50,650 		5,000 +inf% 10.13 US$50,650